Development of the drug fibronectin and substantiation of its use to stimulate corneal healing

D. M. Zubairov , I. V. Brikman , O. D. Zinkevich , R. I. Litvinov , S. I. Ibadova , R. T. Isaeva , A. F. Harrasov , N. A. Safina , G. A. Yermolin , V. E. Kotelyansky , E. E. Efremov , E. V. Arzamastsev

Kazan medical journal ›› 1989, Vol. 70 ›› Issue (1) : 48 -50.

PDF
Kazan medical journal ›› 1989, Vol. 70 ›› Issue (1) : 48 -50. DOI: 10.17816/kazmj99767
Articles
research-article

Development of the drug fibronectin and substantiation of its use to stimulate corneal healing

Author information +
History +
PDF

Abstract

The urgency of the search for remedies accelerating corneal healing after its accidental and surgical injuries is obvious. In recent years, along with physical factors, some natural and synthetic substances, fibronectin turned out to be among the most promising therapeutic agents. It is an adhesive protein of connective tissue involved in cell attachment to fibrillar substrates, formation of collagen fibers and intercellular substance. Fibronectin and its fragments have chemotactic activity and can accelerate phagocytosis reactions by macrophages and neutrophils, acting as a non-specific opsonin against many exo- and endogenous pathological microparticles. One form of this protein, called plasma fibronectin, is present in blood and has many biological properties in common with tissue fibronectin.

Keywords

Kazan Medical archive

Cite this article

Download citation ▾
D. M. Zubairov, I. V. Brikman, O. D. Zinkevich, R. I. Litvinov, S. I. Ibadova, R. T. Isaeva, A. F. Harrasov, N. A. Safina, G. A. Yermolin, V. E. Kotelyansky, E. E. Efremov, E. V. Arzamastsev. Development of the drug fibronectin and substantiation of its use to stimulate corneal healing. Kazan medical journal, 1989, 70(1): 48-50 DOI:10.17816/kazmj99767

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Berman М., Manseau Е., Law М., Aiken D.//Invest. Ophtalmol. Vis. Sсi.— 1983.— Vol. 24.— P. 1358—1366.

[2]

Kawaba T., Nakanasu K., Kanai A.//Acta Soc. Ophtalmol. Jpn.— 1984.— Vol. 88.— P. 1237— 1249.

[3]

Nishida T., Nakagawa S., Ohashi T.//Jap. J. Ophtalmol.— 1982.— Vol. 26.— P. 410—415.

[4]

Nishida T., Nakagawa S., Awata T. et al.//J. Cell Biol.— 1983.— Vol. 97.— Part. 1.- P. 1653—1657.

[5]

Nishida T., Nakagawa S., Nishibauashi C. et al.//Arch. Ophtalmol.— 1984.— Vol. 102.— P. 455—456.

[6]

Surgue S. P., Hay E. D.//J. Cell Biol.— 1981.— Vol. 91.— P. 459—564.

[7]

Surgue S. P., Hay E. D.//J. Cell Biol.— 1981.-Vol. 91.— Part. 2.— P. 159a.

[8]

Uitto V. J., Scwartz D., Veis A.//Eur. J. Biochem.— 1980.— Vol. 105.— P. 409—417.

[9]

Watanabe T.//Acta Soc. Ophtalmol. Jpn.— 1984.— Vol. 86.— P. 298—306.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

102

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/